Stifel lowered the firm’s price target on Inspire Medical (INSP) to $190 from $200 and keeps a Hold rating on the shares. The firm notes in ...

In today’s fast-paced world, maintaining a healthy lifestyle can be challenging. Whether you’re dealing with chronic pain, ...

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision ...

INSP's revenue growth in the fourth quarter is likely to have been boosted by increased market penetration in existing centers and expansion into new implanting centers.

Stifel analysts adjusted their outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target to $190 from the previous $200 while maintaining a Hold rating on the stock. The revision ...

The firm highlighted Inspire Medical's solid performance ... increase throughput at medical centers, simplify the procedure for ear, nose, and throat (ENT) surgeons, and reduce adverse event ...

Inspire Medical Systems, Inc. INSP announced preliminary ... the Netherlands and Belgium while it began reimbursement procedures in France. We expect this trend for both its domestic and ...

The cartoonist’s range is as impressive as it is irritating (how can one person draw perfectly in so many different styles?), ...

January is National Blood Donor Month. The act of donating blood is a simple yet powerful way to contribute to the well-being ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.